Q&A: JP Mor­gan’s new life sci­ences pri­vate cap­i­tal leader on the bank’s ex­pand­ing am­bi­tions, vet­ting star­tups and Abu Dhabi’s biotech push

Long­time biotech en­tre­pre­neur and in­vestor Stephen Squin­to helped build biotech gi­ants Re­gen­eron and Alex­ion be­fore mov­ing to the in­vest­ment world at Or­biMed Ad­vi­sors. Now, one year in­to his ap­point­ment as the chief in­vest­ment of­fi­cer and man­ag­ing part­ner of JP Mor­gan’s nascent Life Sci­ences Pri­vate Cap­i­tal — the firm’s first-ever ef­fort in the ear­ly-stage space — he has yet to place a bet.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER